Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986;24(6):386-90.
doi: 10.1007/BF00377957.

Functional requirements of (Phe, G)-A--L-specific T-cell clones of (H-2b X H-2k)F1 origin

Functional requirements of (Phe, G)-A--L-specific T-cell clones of (H-2b X H-2k)F1 origin

O Axelrod et al. Immunogenetics. 1986.

Abstract

T-cell clones specific for the synthetic polypeptide antigen poly(LPhe, LGlu)-poly(DLAla)--poly(LLys) of (C57BL/6 X C3H/HeJ)F1 origin were tested for their biological activities. One group of clones was restricted in its proliferative response to the H-2b haplotype, the second to the H-2k haplotype, and the third to the F1 unique Ia determinants. All the clones which proliferated in response to antigen secreted interleukin-2 (IL-2) following stimulation. The H-2 restriction of the IL-2 secretion was the same as that of the proliferation. Two of the clones tested, C.6 and C.10, could provide help to B cells in antibody production. However, the genetic restriction profile of the helper activity was less stringent than that for the proliferative response. Thus, C.6, which proliferated in the presence of F1 antigen-presenting cells only, could help B cells and accessory cells of C3H/HeJ. C.10, which was restricted in its proliferative response to the H-2b haplotype, could collaborate with B cells and accessory cells of the H-2k haplotype as well. The antibody response of both clones was restricted to the parental or F1 strains.

PubMed Disclaimer

Similar articles

References

    1. Nature. 1977 Jul 14;268(5616):154-6 - PubMed
    1. Immunol Rev. 1981;54:57-79 - PubMed
    1. J Exp Med. 1980 Jan 1;151(1):194-203 - PubMed
    1. J Exp Med. 1982 Aug 1;156(2):350-60 - PubMed
    1. Immunobiology. 1986 Aug;172(1-2):99-109 - PubMed